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Abstract 
Background: This study examined the accuracy of cardiopulmonary exercise testing (CPET) 
on a treadmill (TM) and recumbent ergometry (RE) in the predicting coronary artery disease 
(CAD) severity and prognosis.  
Methods: Forty Caucasian subjects, mean age 63.5±7.6, with significant coronary artery 
lesions (≥50%) were included. Within two months of coronary angiography, TM and RE 
CPET were performed on two visits 2-4 days apart and subsequently followed up to 32±10 
months.  
Results: Mean left ventricular ejection fraction was 56.7±9.6%. TM CPET exhibited a higher 
occurrence of ST segment depression ≥1 mm (71.05% vs 28.95%, p=0.04). Subjects with 1-2 
stenotic coronary arteries (SCA) demonstrated a better CPET response compared to those 
with 3-SCA. ROC analysis revealed a high predictive value for the ventilation/carbon dioxide 
production (VE/VCO2) slope obtained on TM (area 0.84, p=0.003, Sn 88.9%, Sp 72%) in 
distinguishing between 1-2-SCA and 3-SCA. Among all CPET parameters, work efficiency 
(∆VO2/∆WR) during RE predicted cumulative cardiac events (p<0.01).  
Conclusions: CPET parameters hold predictive value for CAD severity and prognosis. CPET 
on a TM appears to be more reliable in the quantification of CAD compared to RE. 
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Highlights 
 
 Cardiopulmonary exercise testing parameters hold predictive value for coronary artery 
disease severity and prognosis  
 The ventilatory efficiency obtained on a treadmill has a high predictive value in dis-
tinguishing between 1-2- vessel and 3-vessel coronary artery disease 
 Work efficiency obtained during cardiopulmonary exercise testing on a recumbent 
ergometer predicts cumulative cardiac events 
 Treadmill testing is potentially better approach in the coronary artery disease quantifi-
cation 
 
Introduction 
Improving diagnostic accuracy of standard exercise testing (SET) is important in clin-
ical practice.[1,2] The addition of ventilatory gas exchange analysis to SET [i.e. cardiopul-
monary exercise testing (CPET)] is yielding a greater sensitivity and specificity in detection 
of coronary artery disease (CAD).[3,4] Diagnostic accuracy of CPET in CAD was previously 
demonstrated using upright cycle-ergometer, however using other stress modalities requires 
further investigations.[3,4,5] The aim of the present study was to assess the ability of selected 
CPET variables, obtained using treadmill (TM) and recumbent ergometer (RE) testing, to 
predict CAD severity and prognosis. 
Methods: 
The study recruited 40 Caucasian patients with coronary arteries lesions (≥50%). All 
patients were clinically stable and did not exercise regularly. Exclusion criteria were chronic 
heart failure, unstable angina, recent acute coronary syndrome, uncontrolled hypertension and 
diabetes, anaemia and respiratory disease. Nitrates were stopped 24h, calcium antagonists 
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48h, and beta blockers 3 days before testing. The study was approved by the local Ethics 
Committee; all participants provided written informed consent.  
Within two months of coronary angiography, patients performed two CPET (two-four 
days in between), one on a RE using a ramp increase in work rate (WR) and the other on a 
TM using the standard Bruce protocol. Tests were symptom-limited (i.e. fatigue, dyspnea,  
angina), or were stopped when one of the following criteria was met: achieving respiratory 
exchange ratio (RER)≥1.1; a hypertensive response to exercise (≥230/130 mmHg); or ≥2 mm 
ST depression in at least two adjacent leads. Breath-by-breath data were collected using a 
Cardiovit CS200 device (Schiller, Baar, Switzerland). Oxygen consumption (VO2), carbon-
dioxide output (VCO2), minute ventilation (VE), and the end-tidal partial pressure of CO2 
(PETCO2) were determined at rest and peak exercise. PeakVO2 and the peakRER was the av-
erage of last 15s of CPET. VO2 and PETCO2 were also determined at ventilatory threshold 
(VAT–calculated with V-slope method).  ΔVO2/ΔWR was determined during RE-CPET. The 
ΔVO2/ΔWRslope was calculated as (peakVO2-unloadedVO2)/T-0.75xS (T-time of incremen-
tal exercise, S-slope of WR increment in W/min).[5] A ΔVO2/ΔWR inflection >30º outside 
of the last 30s of the test was defined as an ischemic response. O2pulse flattening duration 
was calculated from the inflection point in ΔVO2/ΔWR to peak exercise and expressed in se-
conds.[3,7] 
All patients underwent standard echocardiography at rest[8], and coronary angi-
ography using Judkins' technique.[9] Stenosis was considered significant if there was a ≥50% 
reduction in luminal diameter. The number of stenotic coronary arteries (SCA) was deter-
mined and also dichotomously categorized as 1-2-SCA or 3-SCA. 
Patients were followed after the second CPET, for 32±10 months, or until occurrence 
of an adverse event. The outcome measures were all-cause mortality or cardiovascular mor-
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bidity [i.e., acute coronary syndrome, hospitalization, percutaneous coronary intervention 
(PCI), or coronary artery bypass surgery (CABG)]. 
 The differences between parameters were assessed by the Students’s t-test. Logistic 
regression analysis was used to identify the best model of prediction. Hierarchical models 
were compared using Receiver Operating Characteristic (ROC) curve as measure of predic-
tive ability. Two-by-two tables were built to estimate sensitivity, specificity, predictive val-
ues and 95% confidence intervals of CPET parameters versus coronary angiography. Kaplan-
Meier survival curves examined the ability of CPET variable that gauged CAD severity to 
predict cumulative cardiac event occurrence rate. Statistical tests were considered significant 
when a two-tailed p-value was <0.05. The SPSS software package (SPSS version 17.0, SPSS 
Inc., Chicago, Illinois, USA) was used for all statistical analyses. 
 
Results: 
The mean age of the study participants was 63.5±7.6 years. There were no major car-
diac events during CPET. Mean left ventricular ejection fraction was 56.7±9.6%. Spirometry 
parameters demonstrated a normal response. 
Parameters of CAD severity derived from coronary angiography are listed as follows: 
number of patients with 1-SCA 16, 2-SCA 14, 3-SCA 10.  
TM-CPET had a higher occurrence of CPET termination due to ST segment depres-
sion (p=0.04) [77.1% vs. 28.6%; 73.1% vs. 23.1% in patients with 1-2-SCA; 88.9% vs. 
44.4% in patients with 3-SCA). There were no hypertensive responses to exercise. Chest 
pain, dyspnea or fatigue were present in 44.7% of subjects during TM-CPET and 35.1% dur-
ing RE-CPET. The rest of subjects reached metabolic criteria for maximal exertion (i.e., peak 
RER≥1.1). 
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 Participants divided into groups according to the number of SCA, showed a number 
of significant differences in CPET responses during the TM testing only (Table 1).  
ROC analysis was used to identify parameters distinguishing patients with 1-2-vessel-
CAD compared to 3-vessel-CAD. The best predictive ability was shown for the 
VE/VCO2slope obtained during TM-CPET (area under ROC curve 0.84, SE=0.07, p=0.003). 
The optimal threshold value for identifying patients with 3-vessel-CAD </≥32, produced a 
sensitivity and specificity of 88.9% and 72.0%, respectively (Figure 1). The correlation coef-
ficient between the VE/VCO2slope and number of SCA was r=0.51, p=0.002. 
During 32±10 months of follow-up there were 0(0%) deaths, 6(15%) myocardial in-
farctions, 8(20%) hospitalizations, 32(80%) revascularization procedures (CABG or PCI).  
∆VO2/∆WR correlated with cumulative cardiovascular event occurrence (r=-0.46, 
p=0.01) and was a significant predictor on univariate analysis (F=7.57, p=0.01). 
VE/VCO2slope obtained during TM-CPET, with cut of point of 32, showed tendency 
to distinguish patients with and without cardiovascular event occurrence during the follow-up 
period but did not reach statistical significance (Log Rank-Mantel Cox 2.77, p=0.09). 
 
Discussion: 
The major findings of the present study suggest that ventilatory efficiency obtained 
during TM-CPET demonstrates high sensitivity and specificity to quantify severity of CAD, 
and that work efficiency obtained during RE-CPET is a strong predictor of prognosis in 
CAD.  
The CPET has been proposed as an additional tool in detecting CAD, predicated on its 
ability to detect a decrease in stroke volume due to ischemia by O2pulse and 
∆VO2/∆WRslope measurements.[3,10,11] Present study findings support notion that 
VE/VCO2slope is a sensitive marker of CAD.[12] Moreover, there is a clinical need for more 
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precision in characterizing the functional consequences of myocardial ischemia in patients 
planned for invasive procedures.[13] Present study extricated the VE/VCO2slope obtained 
during TM-CPET as a powerful marker able to differentiate between 3-vessel and 1-2-vessel-
CAD, demonstrating an additional value in the quantification of CAD beyond SET and 
stress-echocardiography. The independence of VE/VCO2slope on subjectivity of the inter-
preter and from effort[14], makes this finding even stronger, as many patients with CAD 
demonstrate symptoms or ST depression before reaching metabolic maximum. Thus, CPET 
appears to be useful in the quantification of CAD severity and burden of ischemia, which is 
important for subsequent revascularization strategies (i.e., PCI or CABG). Although it is 
more informative to perform CPET than a SET in CAD patients, the accessibility of CPET in 
certain settings does limit its broad application. 
TM testing and upright cycle-ergometry constitute the most common modes of 
SET.[7] Previously recommended CPET measurements for detection of CAD require cycle-
ergometer, which has limited broader CPET adoption in clinical practice.[8] Current study 
demonstrates that CPET responses indicate significant differences between 1-2-SCA and 3-
SCA using TM-CPET only. It was also noticeable that ST segment changes were more pro-
nounced during TM-CPET. The physiological basis of this finding may be attributable to a 
more extensive recruitment of muscle groups with a higher metabolic demands during TM 
compared to cycle-ergometry.[15,16,17] 
The present study revealed that ∆VO2/∆WRslope, which can be only obtained during 
cycle-ergometry, holds prognostic value in CAD. However, VE/VCO2 slope value of 32, ob-
tained during TM-CPET, demonstrated potential prognostic utility and may reach statistical 
significance in a larger study with more events, supporting the evidence of a significant prog-
nostic utility in cardiac diseases.[18]  
Limitations 
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 The major limitation of the present study is a small to moderate sample size, originat-
ing from hesitation of clinical care teams to perform two subsequent maximal CPETs in pa-
tients with extensive CAD without antianginal therapy. Unlike in clinical conditions, 
cardioprotective drugs, which significantly impact CPET results[19], were stopped before 
CPET to achieve better standardization of the study protocol, limiting the generalizability of 
the results. Since the VE/VCO2slope may be confounded in the presence of other diseases, 
future studies in patients with CAD and comorbidities, individualized protocols and longer 
follow up period, are needed to refine the diagnostic/prognostic potential of the CPET in 
CAD management. Lastly, the applicability of CPET is confined by availability of resources 
needed, limiting its broader adoption. 
Conclusion 
The VE/VCO2slope obtained using treadmill-CPET can be used to accurately differ-
entiate between 3-vessel and 1-2-vessel-CAD. Compared to recumbent cycle-ergometer, the 
treadmill-CPET induces higher metabolic  demand, enabling a more noticeable emergence of 
myocardial ischemia, making it a potentially better approach in the quantification of CAD.  
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Figure legends: 
 
Figure 1. ROC analysis for the VE/VCO2 slope obtained during TM CPET in distinguishing 
between 1 and 2-vessel CAD vs. 3-vessel CAD (area under ROC curve 0.84, SE=0.07, 
p=0.003). The optimal threshold value for identifying patients with 3-vessel CAD </≥32, 
produced a Sn and Sp of 88.9% and 72.0%, respectively. 
 
 
Figure 1S. Kaplan-Meier analysis of VE/VCO2 slope obtained on TM in distinguishing be-
tween patients with and without cardiovascular event occurrence during 32±10 month follow-
up period (Log Rank-Mantel Cox 2.77, p=0.09) 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
Table 1: Differences in CPET parameters in patients with 1- and 2-vessel CAD com-
pared to patients with 3-vessel CAD 
 
 RE TM 
 1-2-SCA 
(n=30) 
3-SCA (n=10) p 1-2-SCA (n=30) 3-SCA 
(n=10) 
p 
Duration (min) 10.95 ± 
1.96 
10.00 ± 2.86 ns 7.58 ± 2.51 4.60 ± 
1.96 
0.003 
HR peak (bpm) 118 ± 19 112 ± 17 ns 127 ± 20 123 ± 15 ns 
Peak VO2 (ml●min
-1
) 1416.00 
± 393.79 
1.226.30 ± 369.13 ns 1753.30 ± 548.12 1405.60 
± 468.54 
0.08 
Peak VO2 (ml●min
-1●kg-1) 18.25 ± 
4.18 
15.26 ± 2.96 0.07 22.43 ± 7.04 17.00 ± 
4.18 
0.03 
∆VO2/kg peak/rest (ml●min
-1●kg-1) 13.45 ± 
4.13 
11.71 ± 2.66 ns 17.71 ± 5.06 12.92 ± 
3.61 
0.016 
PETCO2 VAT (mmHg) 33.90 ± 
4.06 
33.34 ± 3.92 ns 33.20 ± 4.99 29.57 ± 
2.71 
0.046 
VE/VCO2 slope 29.50 ± 
6.03 
31.77 ± 4.74 ns 30.73 ± 5.27 37.31 ± 
4.65 
0.002 
O2 pulse peak (ml/beat) 12.04 ± 
3.09 
11.32 ± 3.53 ns 13.88 ± 3.94 11.41 ± 
4.51 
ns 
O2 pulse flattening (%) 64.3 50.0 ns    
O2 pulse flattening time (s) 123.75 ± 
98.04 
101.25 ± 92.03 ns - - - 
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∆VO2/∆WR ((ml/min)/watt) 7.99 ± 
2.20 
7.94 ± 2.59 ns - - - 
 
SCA - stenotic coronary arteries, O2 pulse = Oxygen pulse; PETCO2 VAT – End-tidal partial 
pressure of carbon-dioxide at ventilatory anaerobic threshold; RE = recumbent ergometer, 
TM = treadmill, VE = Ventilation; VO2 = Oxygen consumption; VCO2 = Carbon dioxide 
output; ∆VO2/∆WR = Work efficiency, WR = work rate. Values are expressed as mean ± SD.  
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